10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,728,737 | +53.1% | 156,457 | 0.0% | 3.04% | +53.0% |
| Q4 2022 | $5,701,293 | +29.2% | 156,457 | +1.0% | 1.99% | +6.9% |
| Q3 2022 | $4,413,000 | -37.1% | 154,942 | 0.0% | 1.86% | -43.3% |
| Q2 2022 | $7,011,000 | -40.5% | 154,942 | 0.0% | 3.28% | -27.4% |
| Q1 2022 | $11,786,000 | -48.9% | 154,942 | 0.0% | 4.53% | -43.4% |
| Q4 2021 | $23,080,000 | +2.5% | 154,942 | +0.2% | 8.00% | -1.9% |
| Q3 2021 | $22,507,000 | -18.6% | 154,603 | +9.4% | 8.16% | -18.2% |
| Q2 2021 | $27,661,000 | -3.7% | 141,258 | -11.0% | 9.97% | -14.4% |
| Q1 2021 | $28,735,000 | +20.3% | 158,758 | -5.9% | 11.65% | +13.0% |
| Q4 2020 | $23,896,000 | +17.3% | 168,758 | +3.3% | 10.31% | +6.6% |
| Q3 2020 | $20,368,000 | +15.8% | 163,366 | -17.0% | 9.67% | +8.3% |
| Q2 2020 | $17,589,000 | +36.0% | 196,938 | -5.1% | 8.94% | +16.3% |
| Q1 2020 | $12,936,000 | – | 207,578 | – | 7.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |